Publication | Closed Access

Activation of AMPK by triptolide alleviates nonalcoholic fatty liver disease by improving hepatic lipid metabolism, inflammation and fibrosis

Metabolic SyndromeHepatologyTriptolide AlleviatesLiver PhysiologyHepatic Lipid MetabolismMedicinePathologyHepatotoxicityLiver DiseaseFatty Liver DiseasePharmacologyDrug-induced Liver InjuryLipid SynthesisHealth Sciences